Current trends and landscape of drug resistance in renal cell carcinoma: a bibliometric analysis

被引：0
|
作者：
Kenan Zhang [1 ]
Shixu Chen [1 ]
Zhenzhen Zhou [1 ]
Shuanbao Yu [1 ]
Yonghao Zhan [1 ]
Xuepei Zhang [1 ]
机构：
[1] the First Hospital Affiliated to Zhengzhou University,Department of Urology
来源：
Discover Oncology | / 16卷 / 1期
关键词：
Bibliometric analysis; Renal cell carcinoma; Drug resistance; Targeted therapy; Visualization; Immunotherapy;
D O I：
10.1007/s12672-025-02594-0
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Top 100 most-cited articles on renal cell carcinoma: A bibliometric analysis
    Zhou, Huiyu
    Cui, Fan
    Lv, Dingyang
    Gong, Qian
    Wen, Jie
    Shuang, Weibing
    MEDICINE, 2023, 102 (06) : E32926
  • [22] Bibliometric analysis on the progress of immunotherapy in renal cell carcinoma from 2003-2022
    Zhu, Haiyan
    Wang, Xin
    Lu, Shihao
    Wu, Jianqiang
    Ou, Kongbo
    Li, Na
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (02)
  • [23] Emerging strategies to overcome the resistance to current mTOR inhibitors in renal cell carcinoma
    Santoni, Matteo
    Pantano, Francesco
    Amantini, Consuelo
    Nabissi, Massimo
    Conti, Alessandro
    Burattini, Luciano
    Zoccoli, Alice
    Berardi, Rossana
    Santoni, Giorgio
    Tonini, Giuseppe
    Santini, Daniele
    Cascinu, Stefano
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2014, 1845 (02): : 221 - 231
  • [24] Immunotherapy for metastatic renal cell carcinoma: A brief history, current trends, and future directions
    Rambhia, Ami
    Patel, Rutul D.
    Okhawere, Kennedy E.
    Korn, Talia G.
    Badani, Ketan K.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (10) : 664 - 677
  • [25] Global research landscape and trends of lung cancer immunotherapy: A bibliometric analysis
    Liu, Yanhao
    Cheng, Xu
    Han, Xiaona
    Cheng, Xi
    Jiang, Shu
    Lin, Yaru
    Zhang, Zhen
    Lu, Linlin
    Qu, Baozhen
    Chen, Yuxian
    Zhang, Xiaotao
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [26] Non-coding RNAs in renal cell carcinoma: Implications for drug resistance
    Liu, Yiqi
    Zhang, Hu
    Fang, Yuan
    Tang, Dongshan
    Luo, Zhigang
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 164
  • [27] Combination drug regimens for metastatic clear cell renal cell carcinoma
    Khetani, Viraj V.
    Portal, Daniella E.
    Shah, Mansi R.
    Mayer, Tina
    Singer, Eric A.
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2020, 11 (08):
  • [28] Current Immunotherapies for Renal Cell Carcinoma
    Al-Marrawi, Mhd. Yaser
    Holder, Sheldon L.
    CURRENT MOLECULAR PHARMACOLOGY, 2016, 9 (03) : 252 - 263
  • [29] The Changing Landscape of Management of Metastatic Renal Cell Carcinoma: Current Treatment Options and Future Directions
    Nicholas J. Salgia
    Yash Dara
    Paulo Bergerot
    Meghan Salgia
    Sumanta K. Pal
    Current Treatment Options in Oncology, 2019, 20
  • [30] Bibliometric analysis of antimalarial drug resistance
    Zhang, Jialu
    Shahbaz, Muhammad
    Ijaz, Muhammad
    Zhang, Huimin
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
12345